505 related articles for article (PubMed ID: 16634904)
1. Clindamycin and rifampicin combination therapy for hidradenitis suppurativa.
Mendonça CO; Griffiths CE
Br J Dermatol; 2006 May; 154(5):977-8. PubMed ID: 16634904
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients.
Gener G; Canoui-Poitrine F; Revuz JE; Faye O; Poli F; Gabison G; Pouget F; Viallette C; Wolkenstein P; Bastuji-Garin S
Dermatology; 2009; 219(2):148-54. PubMed ID: 19590173
[TBL] [Abstract][Full Text] [Related]
3. Rifampicin and clindamycin for hidradenitis.
Wall D; Kirby B
J Am Acad Dermatol; 2011 Apr; 64(4):790. PubMed ID: 21414503
[No Abstract] [Full Text] [Related]
4. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.
Caposiena Caro RD; Cannizzaro MV; Botti E; Di Raimondo C; Di Matteo E; Gaziano R; Bianchi L
J Am Acad Dermatol; 2019 May; 80(5):1314-1321. PubMed ID: 30502416
[TBL] [Abstract][Full Text] [Related]
5. The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa.
van der Zee HH; Boer J; Prens EP; Jemec GB
Dermatology; 2009; 219(2):143-7. PubMed ID: 19590174
[TBL] [Abstract][Full Text] [Related]
6. Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation.
Caposiena Caro RD; Molinelli E; Brisigotti V; Offidani A; Bianchi L
Clin Exp Dermatol; 2021 Jan; 46(1):96-102. PubMed ID: 32683727
[TBL] [Abstract][Full Text] [Related]
7. Why rifampin (rifampicin) is a key component in the antibiotic treatment of hidradenitis suppurativa: a review of rifampin's effects on bacteria, bacterial biofilms, and the human immune system.
Scheinfeld N
Dermatol Online J; 2016 Jun; 22(6):. PubMed ID: 27617596
[TBL] [Abstract][Full Text] [Related]
8. Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up.
Dessinioti C; Zisimou C; Tzanetakou V; Stratigos A; Antoniou C
Clin Exp Dermatol; 2016 Dec; 41(8):852-857. PubMed ID: 27753139
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa.
Join-Lambert O; Coignard H; Jais JP; Guet-Revillet H; Poirée S; Fraitag S; Jullien V; Ribadeau-Dumas F; Thèze J; Le Guern AS; Behillil S; Leflèche A; Berche P; Consigny PH; Lortholary O; Nassif X; Nassif A
Dermatology; 2011 Feb; 222(1):49-58. PubMed ID: 21109728
[TBL] [Abstract][Full Text] [Related]
10. Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination.
Join-Lambert O; Ribadeau-Dumas F; Jullien V; Kitzis MD; Jais JP; Coignard-Biehler H; Guet-Revillet H; Consigny PH; Delage M; Nassif X; Lortholary O; Nassif A
Eur J Dermatol; 2014; 24(1):94-5. PubMed ID: 24445967
[No Abstract] [Full Text] [Related]
11. Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study.
Marasca C; Annunziata MC; Villani A; Volpe S; Marasca D; Fabbrocini G
J Drugs Dermatol; 2019 May; 18(5):437-438. PubMed ID: 31141853
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic Treatment of Hidradenitis Suppurativa.
Bettoli V; Join-Lambert O; Nassif A
Dermatol Clin; 2016 Jan; 34(1):81-9. PubMed ID: 26617361
[TBL] [Abstract][Full Text] [Related]
13. Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: can some factors influence the response to the treatment?
Bettoli V; Zauli S; Virgili A
G Ital Dermatol Venereol; 2016 Apr; 151(2):216-8. PubMed ID: 27068603
[No Abstract] [Full Text] [Related]
14. Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients.
Bettoli V; Zauli S; Borghi A; Toni G; Minghetti S; Ricci M; Virgili A
J Eur Acad Dermatol Venereol; 2014 Jan; 28(1):125-6. PubMed ID: 23451831
[No Abstract] [Full Text] [Related]
15. The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study.
van Straalen KR; Tzellos T; Guillem P; Benhadou F; Cuenca-Barrales C; Daxhelet M; Daoud M; Efthymiou O; Giamarellos-Bourboulis EJ; Jemec GBE; Katoulis AC; Koenig A; Lazaridou E; Marzano AV; Matusiak Ł; Molina-Leyva A; Moltrasio C; Pinter A; Potenza C; Romaní J; Saunte DM; Skroza N; Stergianou D; Szepietowski J; Trigoni A; Vilarrasa E; van der Zee HH
J Am Acad Dermatol; 2021 Aug; 85(2):369-378. PubMed ID: 33484766
[TBL] [Abstract][Full Text] [Related]
16. Improved clinical effectiveness of adalimumab when initiated with clindamycin and rifampicin in hidradenitis suppurativa.
Aarts P; van Huijstee JC; van der Zee HH; van Straalen KR; Prens EP
J Eur Acad Dermatol Venereol; 2024 May; 38(5):904-909. PubMed ID: 38112226
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of hidradenitis suppurativa: a 10-year experience.
Kagan RJ; Yakuboff KP; Warner P; Warden GD
Surgery; 2005 Oct; 138(4):734-40; discussion 740-1. PubMed ID: 16269303
[TBL] [Abstract][Full Text] [Related]
18. The Microbiology of Hidradenitis Suppurativa.
Ring HC; Emtestam L
Dermatol Clin; 2016 Jan; 34(1):29-35. PubMed ID: 26617355
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized controlled trial assessing the efficacy of adjunctive hyperbaric oxygen therapy in the treatment of hidradenitis suppurativa.
Yildiz H; Senol L; Ercan E; Bilgili ME; Karabudak Abuaf O
Int J Dermatol; 2016 Feb; 55(2):232-7. PubMed ID: 26267600
[TBL] [Abstract][Full Text] [Related]
20. Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa.
Rosi E; Pescitelli L; Ricceri F; Di Cesare A; Novelli A; Pimpinelli N; Prignano F
Dermatol Ther; 2019 Mar; 32(2):e12792. PubMed ID: 30515931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
